Steger B, Speicher L, Philipp W, Gasser T, Schmid E, Bechrakis N
Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich,
Ophthalmologe. 2014;111(7):644-8. doi: 10.1007/s00347-013-2937-4.
Contact lens-related microbial keratitis is a cause of potentially sight-threatening corneal opacification. Effective initial antimicrobial therapy is crucial to prevent long-term complications. This investigation was undertaken to test the effectiveness of current routine empirical antibiotic treatment regimens.
METHODS/PATIENTS: All consecutive cases of contact lens-related keratitis presenting in the outpatient clinic of the Department of Ophthalmology at the Medical University of Innsbruck between January 2010 and April 2012 were retrospectively analyzed.
Cultures were positive in 69 out of the 123 cases included in the study. Culture results identified 59.4 % Gram positive strains, 50.7 % Gram negative strains and 7.2 % fungal strains. Mixed infections accounted for 29 % of cases. The combination of an aminoglycoside and a second generation quinolone antibiotic was the most common initial treatment regimen (87.8 %). In vitro this regimen was less effective compared to combinations of moxifloxacin and ciprofloxacin or moxifloxacin and gentamicin.
Empirical combined regimens remain an effective treatment of contact lens-related keratitis. Fluoroquinolones proved to be inadequate for monotherapy.
与隐形眼镜相关的微生物性角膜炎是导致潜在视力威胁性角膜混浊的原因之一。有效的初始抗菌治疗对于预防长期并发症至关重要。本研究旨在测试当前常规经验性抗生素治疗方案的有效性。
方法/患者:对2010年1月至2012年4月间因隐形眼镜相关角膜炎就诊于因斯布鲁克医科大学眼科门诊的所有连续病例进行回顾性分析。
该研究纳入的123例病例中,69例培养结果呈阳性。培养结果显示,革兰氏阳性菌占59.4%,革兰氏阴性菌占50.7%,真菌占7.2%。混合感染占病例的29%。氨基糖苷类和第二代喹诺酮类抗生素联合是最常见的初始治疗方案(87.8%)。在体外,该方案与莫西沙星和环丙沙星联合或莫西沙星和庆大霉素联合相比效果较差。
经验性联合治疗方案仍然是治疗隐形眼镜相关角膜炎的有效方法。事实证明,氟喹诺酮类药物单药治疗是不够的。